Over the past six months, The Cigna Group's stock (CI) has experienced various movements: The stock price decreased by 7.02% over the last 12 months, with a year-to-date return of 0.29%. The largest daily move in the past year was a -17.4% close on October 30, 2025. In the past month, the stock increased by 0.30%, but as of September 18, 2026, the share price was $275.28, representing a decline of 5.19% from September 19, 2025. On July 30, 2026, The Cigna Group reported strong second-quarter 2026 results and raised its 2026 outlook, which was followed by a -2.97% change in stock price. The Cigna Group is scheduled to host an Investor Day on September 30, 2026. A quarterly cash dividend of $1.56 per share was scheduled to be paid on September 23, 2026. Executive stock sales and options included a pre-planned $175K stock sale by an executive on September 8, 2026, new stock options and restricted shares granted to the CEO on September 3, 2026, an officer scheduling a September sale of vested shares on September 3, 2026, and the HR chief selling 2,677 shares on August 20, 2026. Product and service developments included Cigna Healthcare expanding AI-enabled personalized support on July 23, 2026, Paul Tudor Jones increasing his position by $28.9M on August 14, 2026, new research from The Cigna Group finding a strong connection between volunteering and health on September 16, 2026, and Cigna Healthcare connecting medical and supplemental benefits on September 23, 2026. Recent share price moves have brought Cigna Group's valuation into focus for investors, with some narratives suggesting it is undervalued.
